Sales/Maturities of Investments

$2.13B

Quarterly · Period ending: Jun 28, 2026 · USD

Latest reported$2.13Bperiod endingJun 28, 2026

PFE Quarterly Sales/Maturities of Investments ($200.10M → $2.13B)

Quarterly Sales/Maturities of Investments

High-resolution chart · PNG

PFE sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Sales/Maturities of Investments — Quarterly (USD)
Period ending	Sales/Maturities of Investments (USD)
Jul 1, 2001	1,502,000,000
Apr 1, 2001	1,946,000,000
Dec 31, 2000	1,096,000,000
Oct 1, 2000	1,147,000,000
Jul 2, 2000	2,473,000,000
Apr 2, 2000	1,876,000,000
Dec 31, 1999	4,344,000,000
Oct 3, 1999	980,000,000
Jul 4, 1999	739,000,000
Apr 4, 1999	1,246,000,000
Dec 31, 1998	1,724,000,000
Sep 27, 1998	826,000,000
Jun 28, 1998	1,073,000,000
Mar 29, 1998	586,000,000
Dec 31, 1997	-1,025,000,000
Sep 28, 1997	483,000,000
Jun 29, 1997	359,000,000
Mar 30, 1997	400,000,000
Dec 31, 1996	926,000,000
Sep 29, 1996	845,000,000
Jun 30, 1996	769,000,000
Mar 31, 1996	950,000,000
Dec 31, 1995	644,400,000
Oct 1, 1995	406,100,000
Jul 2, 1995	648,900,000
Apr 2, 1995	485,200,000
Dec 31, 1994	274,400,000
Oct 2, 1994	358,000,000
Jul 3, 1994	245,800,000
Apr 3, 1994	410,000,000
Dec 31, 1993	382,600,000
Sep 30, 1993	228,900,000
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	-70,300,000
Sep 30, 1992	374,300,000
Jun 30, 1992	71,100,000
Mar 31, 1992	135,700,000
Dec 31, 1991	43,900,000
Sep 30, 1991	14,500,000
Jun 30, 1991	58,600,000
Mar 31, 1991	125,400,000
Dec 31, 1990	16,900,000
Sep 30, 1990	-135,600,000
Jun 30, 1990	115,800,000
Mar 31, 1990	200,100,000